Skip to main content
Premium Trial:

Request an Annual Quote

Charles River Using BioTrove’s OpenArray System in Rodent Pathogen Studies

BioTrove said this week that Charles River Laboratories has purchased an OpenArray system for use in detecting rodent-specific pathogens.
 
Charles River had previously purchased an OpenArray SNP Genotyping system for genetic quality control processes. The firm is designing pathogen panels using OpenArray plates, which can contain between 16 and 3,072 assays and can be loaded with up to 144 samples.
 
“Our new OpenArray system will now enable us to screen samples with custom-designed pathogen panels that utilize our pre-existing fluorogenic PCR technology,” said Kenneth Henderson, director of molecular diagnostics and R&D for Charles River, in a statement.
 
The firm believes its fluorogenic PCR technology is more specific and sensitive than conventional gel-based PCR.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.